Bioscience
Primavera Essentials introduces Neuro-Eze
FORT COLLINS -- Primavera Essentials, Inc. announced the launch of Neuro-Eze, a highly specialized topical gel that may help lessen the pain and numbness that neuropathy patients experience in... Read More
Friday April 30, 2021
Reven Holdings announces first patient dosed in clinical trial evaluating RJX for high-risk COVID-19
WESTMINSTER -- Reven Holdings, Inc. today announced the first patient has been dosed in the Phase I/II trial of RJX in high-risk COVID-19 patients ( ClinicalTrials.gov Identifier: NCT04708340; ... Read More
Thursday April 29, 2021
KromaTiD receives $2M of growth investment from BroadOak Capital Partners
LONGMONT -- KromaTiD announced BroadOak Capital Partners made a $2M investment in the company. KromaTiD said its sales and operations are rapidly accelerating, driven by growing market... Read More
Thursday April 29, 2021
Ampio: Ampion reduces all-cause mortality in COVID-19 respiratory distress by nearly 80%
ENGLEWOOD -- Ampio Pharmaceuticals (NYSE American: AMPE) announced positive results in its AP-014 Phase I clinical trial utilizing inhaled Ampion in treating respiratory distress in patients as a... Read More
Wednesday April 28, 2021
CereHealth granted patent for medical imaging quantification
DENVER -- CereHealth Corporation announced it has been granted a third patent on its novel systems and methodologies used in its FDA-cleared CereMetrix medical imaging and data analytics software. ... Read More
Friday April 23, 2021
Research shows Ampion mimics anti-inflammatory effects of steroids but without adverse effects
ENGLEWOOD -- Ampio Pharmaceuticals (NYSE American: AMPE) announced findings of pre-clinical research demonstrating Ampio's lead drug candidate, Ampion, provides some of the same anti-inflammatory... Read More
Tuesday April 20, 2021
VieCure announces $25M Series A investment led by Northpond Ventures to improve oncology care, scale A.I. and patient-focused technologies
DENVER -- VieCure , Inc . today announced the closing of a $25 million Series A growth equity investment, led by Northpond Ventures . An undisclosed investor is also contributing to the... Read More
Tuesday April 20, 2021
TriSalus Life Sciences and MD Anderson Cancer Center announce research collaboration to evaluate treatment of solid tumors
DENVER -- The University of Texas MD Anderson Cancer Center and Denver-based TriSalus Life Sciences announced a strategic research collaboration to evaluate the treatment of tumors of the... Read More
Thursday April 15, 2021
IN Sponsors
Browse
Entrepreneurial by Nature
